Genomic Landscape of HCC

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Hepatocellular carcinoma (HCC) is a major global cause of cancer mortality with limited therapeutic strategies.
• Chronic hepatitis, fibrosis, and liver regeneration contribute to the genomic alterations driving HCC development.

Purpose of the Study:

• To review recent advances in understanding the molecular landscape of HCC.
• To summarize key genetic and epigenetic changes identified through next-generation sequencing (NGS).
• To highlight emerging molecular and immunotherapies targeting HCC-specific events.

Main Methods:

• Review of studies utilizing next-generation sequencing (NGS) technologies.
• Analysis of identified somatic mutations and epigenetic alterations in HCC.
• Synthesis of data on novel therapeutic approaches.

Main Results:

• NGS has identified specific genetic and molecular pathways crucial for hepatocarcinogenesis.
• Major somatic mutations and epigenetic modifications in HCC have been elucidated.
• Promising targeted molecular therapies and immunotherapies are being developed.

Conclusions:

• The genomic profile of HCC is highly complex and heterogeneous.
• Ongoing research is crucial for deciphering HCC's molecular drivers.
• New therapeutic strategies show promise for treating HCC.